Pieter Postmus
Pieter Postmus
LUMC
Verifierad e-postadress på lumc.nl
Titel
Citeras av
Citeras av
År
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
P Goldstraw, J Crowley, K Chansky, DJ Giroux, PA Groome, R Rami-Porta, ...
Journal of thoracic oncology 2 (8), 706-714, 2007
4232*2007
Prophylactic cranial irradiation in extensive small-cell lung cancer
B Slotman, C Faivre-Finn, G Kramer, E Rankin, M Snee, M Hatton, ...
New England Journal of Medicine 357 (7), 664-672, 2007
10852007
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
H Van Tinteren, OS Hoekstra, EF Smit, JHAM Van Den Bergh, ...
The Lancet 359 (9315), 1388-1392, 2002
9582002
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ...
Nature 545 (7655), 446-451, 2017
9462017
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
PE Postmus, KM Kerr, M Oudkerk, S Senan, DA Waller, J Vansteenkiste, ...
Annals of Oncology 28, iv1-iv21, 2017
8442017
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension
SA van Wolferen, JT Marcus, A Boonstra, KMJ Marques, JGF Bronzwaer, ...
European heart journal 28 (10), 1250-1257, 2007
7762007
Allele-specific HLA loss and immune escape in lung cancer evolution
N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ...
Cell 171 (6), 1259-1271. e11, 2017
5832017
Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM …
P Goldstraw, J Crowley, K Chansky, DJ Giroux, PA Groome, R Rami-Porta, ...
J Thorac Oncol 2 (8), 706-714, 2007
5752007
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
D Curran, T Sahmoud, P Therasse, J van Meerbeeck, PE Postmus, ...
Journal of Clinical Oncology 16 (1), 145-152, 1998
5461998
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European …
A Ardizzoni, H Hansen, P Dombernowsky, T Gamucci, S Kaplan, ...
Journal of Clinical Oncology 15 (5), 2090-2096, 1997
5301997
The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming …
FA Shepherd, J Crowley, P Van Houtte, PE Postmus, D Carney, ...
Journal of thoracic oncology 2 (12), 1067-1077, 2007
4952007
Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer
K Kok, J Osinga, B Carritt, MB Davis, AH van der Hout, AY van der Veen, ...
Nature 330 (6148), 578-581, 1987
4691987
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the …
E Vallieres, FA Shepherd, J Crowley, P Van Houtte, PE Postmus, ...
Journal of thoracic oncology 4 (9), 1049-1059, 2009
4432009
Current aspects of spontaneous pneumothorax
FM Schramel, PE Postmus, RG Vanderschueren
European Respiratory Journal 10 (6), 1372-1379, 1997
4141997
Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension
CTJ Gan, JW Lankhaar, N Westerhof, JT Marcus, A Becker, JWR Twisk, ...
Chest 132 (6), 1906-1912, 2007
3752007
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment …
G Giaccone, TA Splinter, C Debruyne, GS Kho, P Lianes, N Van Zandwijk, ...
Journal of clinical oncology 16 (6), 2133-2141, 1998
3251998
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs
AAM Van der Veldt, M Lubberink, I Bahce, M Walraven, MP de Boer, ...
Cancer cell 21 (1), 82-91, 2012
3162012
Quantification of right ventricular afterload in patients with and without pulmonary hypertension
JW Lankhaar, N Westerhof, TJC Faes, KMJ Marques, JT Marcus, ...
American Journal of Physiology-Heart and Circulatory Physiology 291 (4 …, 2006
3072006
Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non …
CJ Hoekstra, SG Stroobants, EF Smit, J Vansteenkiste, H Van Tinteren, ...
Journal of clinical oncology 23 (33), 8362-8370, 2005
3072005
Right ventricular diastolic impairment in patients with pulmonary arterial hypertension
S Rain, ML Handoko, P Trip, CTJ Gan, N Westerhof, GJ Stienen, ...
Circulation 128 (18), 2016-2025, 2013
2952013
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20